Hans Carl Carl Hasselbalch (Hans Hasselbalch, Hans Carl Hasselbalch, Hans C Hasselbalch)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 55

Top Topics

Combination Therapy

Extracellular Matrix

Chronic Myeloid Leukemia

Top Venues

European journal of haematology

Blood cancer journal

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Christina Schjellerup Eickhardt-Dalbøge, Henrik Vedel Nielsen, Kurt Fuursted, Christen Rune Stensvold, Lee O' Brien Andersen, Berit Lilje, Morten Kranker Larsen, Lasse Kjaer, Sarah Friis Christensen, Trine Alma Knudsen, Vibe Skov, Anders Lindholm Sørensen, Christina Ellervik, Lars Rønn Olsen, Jens Jørgen Elmer Christensen, Xiaohui Chen Nielsen, Hans Carl Carl Hasselbalch, Anna Cäcilia Ingham
JAK2V617F drives gut microbiota differences in patients with myeloproliferative neoplasms. European journal of haematology 112 (5) (2024)
Sylvie Hermouet, Hans Carl Carl Hasselbalch
Interleukin-1β, JAK2V617F mutation and inflammation in MPNs. Blood advances 8 (16) (2024)
Hans Carl Carl Hasselbalch, Marie Hvelplund Kristiansen, Lasse Kjaer, Vibe Skov, Morten Kranker Larsen, Christina Ellervik, Troels Wienecke
CHIP-JAK2V617F, chronic inflammation, abnormal megakaryocyte morphology, organ failure, and multimorbidties. Blood advances 8 (3) (2024)
Christina Schjellerup Eickhardt-Dalbøge, Henrik Vedel Nielsen, Kurt Fuursted, Christen Rune Stensvold, Lee O' Brien Andersen, Berit Lilje, Morten Kranker Larsen, Lasse Kjaer, Sarah Friis Christensen, Trine Alma Knudsen, Vibe Skov, Anders Lindholm Sørensen, Christina Ellervik, Lars Rønn Olsen, Jens Jørgen Elmer Christensen, Xiaohui Chen Nielsen, Hans Carl Carl Hasselbalch, Anna Cäcilia Ingham
JAK2V617F drives gut microbiota differences in patients with myeloproliferative neoplasms. European journal of haematology 112 (5) (2024)
Hans Carl Carl Hasselbalch, Marie Hvelplund Kristiansen, Lasse Kjaer, Vibe Skov, Morten Kranker Larsen, Christina Ellervik, Troels Wienecke
CHIP-JAK2V617F, chronic inflammation, abnormal megakaryocyte morphology, organ failure, and multimorbidties. Blood advances 8 (3) (2024)
Anders Lindholm Soerensen, Vibe Skov, Lasse Kjær, Mads Emil Bjørn, Christina Schjellerup Eickhardt-Dalbøge, Morten Kranker Larsen, Claus Henrik Nielsen, Carsten Thomsen, Lise-Mette Rahbek Gjerdrum, Trine Alma Knudsen, Christina Ellervik, Ulrik Malthe Overgaard, Christen Lykkegaard Andersen, Hans Carl Carl Hasselbalch
Combination Therapy with Ruxolitinib and Pegylated Interferon-alpha2a in Newly Diagnosed Patients with Polycythemia Vera. Blood advances (2024)
Morten Kranker Larsen, Vibe Skov, Lasse Kjær, Christina Schjellerup Eickhardt-Dalbøge, Trine Alma Knudsen, Marie Hvelplund Kristiansen, Anders Lindholm Sørensen, Troels Wienecke, Morten Andersen, Johnny T Ottesen, Johanne Gudmand-Høyer, Jordan Andrew Snyder, Mikkel Porsborg Andersen, Christian Torp-Pedersen, Henrik Enghusen Poulsen, Thomas Stiehl, Hans Carl Carl Hasselbalch, Christina Ellervik
Neutrophil-to-lymphocyte ratio and all-cause mortality with and without myeloproliferative neoplasms-a Danish longitudinal study. Blood cancer journal 14 (1) (2024)
Morten Kranker Larsen, Vibe Skov, Lasse Kjær, Christina Schjellerup Eickhardt-Dalbøge, Trine Alma Knudsen, Marie Hvelplund Kristiansen, Anders Lindholm Sørensen, Troels Wienecke, Morten Andersen, Johnny T Ottesen, Johanne Gudmand-Høyer, Jordan Andrew Snyder, Mikkel Porsborg Andersen, Christian Torp-Pedersen, Henrik Enghusen Poulsen, Thomas Stiehl, Hans Carl Carl Hasselbalch, Christina Ellervik
Neutrophil-to-lymphocyte ratio and all-cause mortality with and without myeloproliferative neoplasms-a Danish longitudinal study. Blood cancer journal 14 (1) (2024)
Sylvie Hermouet, Hans Carl Carl Hasselbalch
Interleukin-1β, JAK2V617F mutation and inflammation in MPNs. Blood advances 8 (16) (2024)
Morten Kranker Larsen, Vibe Skov, Lasse Kjær, Christina Schjellerup Eickhardt-Dalbøge, Trine Alma Knudsen, Marie Hvelplund Kristiansen, Anders Lindholm Sørensen, Troels Wienecke, Morten Andersen, Johnny T Ottesen, Johanne Gudmand-Høyer, Jordan Andrew Snyder, Mikkel Porsborg Andersen, Christian Torp-Pedersen, Henrik Enghusen Poulsen, Thomas Stiehl, Hans Carl Carl Hasselbalch, Christina Ellervik
Neutrophil-to-lymphocyte ratio and all-cause mortality with and without myeloproliferative neoplasms-a Danish longitudinal study. Blood cancer journal 14 (1) (2024)
Daniel Tuyet Kristensen, Andreas Kiesbye Øvlisen, Lasse Hjort Kyneb Jakobsen, Marianne Tang Severinsen, Louise Hur Hannig, Jørn Starklint, Morten Hagemann Hilsøe, Anders Pommer Vallentin, Mette Brabrand, Hans Carl Carl Hasselbalch, Tarec Christoffer El-Galaly, Anne Stidsholt Roug
Metformin use and risk of myeloproliferative neoplasms - a Danish population-based case-control study. Blood advances (2024)
Sylvie Hermouet, Hans Carl Carl Hasselbalch
Interleukin-1beta, JAK2V617F mutation and inflammation in MPNs. Blood advances (2024)
Morten Kranker Larsen, Vibe Skov, Lasse Kjær, Christina Schjellerup Eickhardt-Dalbøge, Trine Alma Knudsen, Marie Hvelplund Kristiansen, Anders Lindholm Sørensen, Troels Wienecke, Morten Andersen, Johnny T Ottesen, Johanne Gudmand-Høyer, Jordan Andrew Snyder, Mikkel Porsborg Andersen, Christian Torp-Pedersen, Henrik Enghusen Poulsen, Thomas Stiehl, Hans Carl Carl Hasselbalch, Christina Ellervik
Neutrophil-to-lymphocyte ratio and all-cause mortality with and without myeloproliferative neoplasms-a Danish longitudinal study. Blood cancer journal 14 (1) (2024)
Hans Carl Carl Hasselbalch, Marie Hvelplund Kristiansen, Lasse Kjaer, Vibe Skov, Morten Kranker Larsen, Christina Ellervik, Troels Wienecke
CHIP-JAK2V617F, chronic inflammation, abnormal megakaryocyte morphology, organ failure, and multimorbidities. Blood advances 8 (3) (2024)
Christina Schjellerup Eickhardt-Dalbøge, Henrik Vedel Nielsen, Kurt Fuursted, Christen Rune Stensvold, Lee O' Brien Andersen, Berit Lilje, Morten Kranker Larsen, Lasse Kjaer, Sarah Friis Christensen, Trine Alma Knudsen, Vibe Skov, Anders Lindholm Sørensen, Christina Ellervik, Lars Rønn Olsen, Jens Jørgen Elmer Christensen, Xiaohui Chen Nielsen, Hans Carl Carl Hasselbalch, Anna Cäcilia Ingham
JAK2V617F drives gut microbiota differences in patients with myeloproliferative neoplasms. European journal of haematology (2024)
Morten Kranker Larsen, Vibe Skov, Lasse Kjær, Christina Schjellerup Eickhardt-Dalbøge, Trine Alma Knudsen, Marie Hvelplund Kristiansen, Anders Lindholm Sørensen, Troels Wienecke, Morten Andersen, Johnny T Ottesen, Johanne Gudmand-Høyer, Jordan Andrew Snyder, Mikkel Porsborg Andersen, Christian Torp-Pedersen, Henrik Enghusen Poulsen, Thomas Stiehl, Hans Carl Carl Hasselbalch, Christina Ellervik
Neutrophil-to-lymphocyte ratio and all-cause mortality with and without myeloproliferative neoplasms-a Danish longitudinal study. Blood cancer journal 14 (1) (2024)
Daniel Tuyet Kristensen, Andreas Kiesbye Øvlisen, Lasse Hjort Kyneb Jakobsen, Marianne Tang Severinsen, Louise Hur Hannig, Jørn Starklint, Morten Hagemann Hilsøe, Anders Pommer Vallentin, Mette Brabrand, Hans Carl Carl Hasselbalch, Tarec Christoffer El-Galaly, Anne Stidsholt Roug
Metformin use and risk of myeloproliferative neoplasms: a Danish population-based case-control study. Blood advances 8 (16) (2024)
Hans Carl Carl Hasselbalch, Marie Hvelplund Kristiansen, Lasse Kjaer, Vibe Skov, Morten Kranker Larsen, Christina Ellervik, Troels Wienecke
CHIP-JAK2V617F, chronic inflammation, abnormal megakaryocyte morphology, organ failure, and multimorbidties. Blood advances 8 (3) (2024)
Yuelian Sun, Katalin Veres, Hans Carl Carl Hasselbalch, Henrik Frederiksen, Lene Sofie Granfeldt Østgård, Erzsébet Horváth-Puhó, Victor W Henderson, Henrik Toft Sorensen
Myeloproliferative Neoplasms and Dementia Risk: A Population-Based Cohort Study. European journal of haematology (2024)
Morten Kranker Larsen, Vibe Skov, Lasse Kjær, Christina Schjellerup Eickhardt-Dalbøge, Trine Alma Knudsen, Marie Hvelplund Kristiansen, Anders Lindholm Sørensen, Troels Wienecke, Morten Andersen, Johnny T Ottesen, Johanne Gudmand-Høyer, Jordan Andrew Snyder, Mikkel Porsborg Andersen, Christian Torp-Pedersen, Henrik Enghusen Poulsen, Thomas Stiehl, Hans Carl Carl Hasselbalch, Christina Ellervik
Neutrophil-to-lymphocyte ratio and all-cause mortality with and without myeloproliferative neoplasms-a Danish longitudinal study. Blood cancer journal 14 (1) (2024)
Daniel Tuyet Kristensen, Andreas Kiesbye Øvlisen, Lasse Hjort Kyneb Jakobsen, Marianne Tang Severinsen, Louise Hur Hannig, Jørn Starklint, Morten Hagemann Hilsøe, Anders Pommer Vallentin, Mette Brabrand, Hans Carl Carl Hasselbalch, Tarec Christoffer El-Galaly, Anne Stidsholt Roug
Metformin use and risk of myeloproliferative neoplasms: a Danish population-based case-control study. Blood advances 8 (16) (2024)
Morten Orebo Holmström, Josephine Hallundbæk Ruders, Caroline Hasselbalch Riley, Morten Kranker Larsen, Jacob Handlos Grauslund, Lasse Kjaer, Vibe Skov, Christina Ellervik, Belinda B Guo, Matthew Linden, Hans Carl Carl Hasselbalch, Mads Hald Andersen
The CALR mutations enhance the expression of the immunosuppressive proteins GARP and LAP on peripheral blood lymphocytes through increased binding of activated platelets. British journal of haematology (2024)
Hans Carl Carl Hasselbalch, Vibe Skov, Lasse Kjaer, Morten Kranker Larsen
Proof of concept of triple COMBI therapy to prohibit MPN progression to AML. British journal of haematology (2023)
Vibe Skov, Mads Thomassen, Lasse Kjaer, Morten Kranker Larsen, Trine A Knudsen, Christina Ellervik, Torben A Kruse, Hans Carl Carl Hasselbalch
Whole blood transcriptional profiling reveals highly deregulated atherosclerosis genes in Philadelphia-chromosome negative myeloproliferative neoplasms. European journal of haematology (2023)
Marie Hvelplund Kristiansen, Lasse Kjær, Vibe Skov, Morten Kranker Larsen, Christina Ellervik, Hans Carl Carl Hasselbalch, Troels Wienecke
CHIP-JAK2V617F, Chronic Inflammation, Abnormal Megakaryocyte Morphology, Organ Failure, and Multimorbidties. Blood advances (2023)
Heinz Gisslinger, Christoph Klade, Pencho Georgiev, Dorota Krochmalczyk, Liana Gercheva-Kyuchukova, Miklos Egyed, Petr Dulicek, Arpad Illes, Halyna Pylypenko, Lylia Sivcheva, Jiří Mayer, Vera Yablokova, Kurt Krejcy, Victoria Empson, Hans Carl Carl Hasselbalch, Robert Kralovics, Jean-Jacques Kiladjian, null null
Event-free survival in patients with polycythemia vera treated with ropeginterferon alfa-2b versus best available treatment. Leukemia (2023)
Daniel Tuyet Kristensen, Andreas Kiesbye Øvlisen, Lasse Hjort Kyneb Jakobsen, Marianne Tang Severinsen, Louise Hur Hannig, Jørn Starklint, Morten Hagemann Hilsøe, Anders Pommer Vallentin, Mette Brabrand, Hans Carl Carl Hasselbalch, Tarec C El-Galaly, Anne Stidsholt Roug
Use of statins and risk of myeloproliferative neoplasms - a Danish nationwide case-control study. Blood advances (2023)
Camilla Nordheim Solli, Sandra Chamat-Hedemand, Hanne Elming, Anh Ngo, Lasse Kjaer, Vibe Skov, Anders Lindholm Sørensen, Christina Ellervik, Hans Carl Carl Hasselbalch, Niels Eske Bruun
High JAK2V617F variant allele frequency is associated with coronary artery but not aortic valve calcifications in patients with Philadelphia-negative myeloproliferative neoplasms. European journal of haematology (2023)
Marie Hvelplund Kristiansen, Lasse Kjær, Vibe Skov, Morten Kranker Larsen, Christina Ellervik, Hans Carl Carl Hasselbalch, Troels Wienecke
JAK2V617F mutation is highly prevalent in patients with ischemic stroke: a case-control study. Blood advances (2023)
Hans Carl Carl Hasselbalch, Peter Junker, Vibe Skov, Lasse Kjær, Trine Alma Knudsen, Morten Kranker Larsen, Morten Orebo Holmström, Mads Hald Andersen, Christina Jensen, Morten A Karsdal, Nicholas Willumsen
Revisiting Circulating Extracellular Matrix Fragments as Disease Markers in Myelofibrosis and Related Neoplasms. Cancers 15 (17) (2023)
Christina Schjellerup Eickhardt-Dalbøge, Anna Cäcilia Ingham, Henrik Vedel Nielsen, Kurt Fuursted, Christen Rune Stensvold, Lee O'Brien Andersen, Morten Kranker Larsen, Lasse Kjaer, Sarah Friis Christensen, Trine Alma Knudsen, Vibe Skov, Christina Ellervik, Lars Rønn Olsen, Hans Carl Carl Hasselbalch, Jens Jørgen Elmer Christensen, Xiaohui Chen Nielsen
Pronounced gut microbiota signatures in patients with JAK2V617F- positive essential thrombocythemia. Microbiology spectrum (2023)
Sarah Friis Christensen, Lise Skovgaard Svingel, Anders Kjaersgaard, Anna Stenling, Bianka Darvalics, Björn Paulsson, Christen Lykkegaard Andersen, Christian Fynbo Christiansen, Jesper Stentoft, Jørn Starklint, Marianne Tang Severinsen, Mette Borg Clausen, Morten Hagemann Hilsøe, Hans Carl Carl Hasselbalch, Henrik Frederiksen, Ellen Margrethe Mikkelsen, Marie Bak
Healthcare resource utilization in patients with myeloproliferative neoplasms: A Danish nationwide matched cohort study. European journal of haematology 109 (5) (2022)
Mathieu Gigoux, Morten Orebo Holmström, Roberta Zappasodi, Joseph J Park, Stephane Pourpe, Cansu Cimen Bozkus, Levi Mark Mangarin, David Redmond, Svena Verma, Sara Schad, Mariam M George, Divya Venkatesh, Arnab Ghosh, David Hoyos, Zaki Molvi, Baransel Kamaz, Anna E Marneth, William Duke, Matthew Joseph Leventhal, Max Jan, Vincent T Ho, Gabriela S Hobbs, Trine Alma Knudsen, Vibe Skov, Lasse Kjær, Thomas Stauffer Larsen, Dennis Lund Hansen, R Coleman Lindsley, Hans Carl Carl Hasselbalch, Jacob H Grauslund, Thomas L Lisle, Özcan Met, Patrick Wilkinson, Benjamin Greenbaum, Manuel A Sepulveda, Timothy A Chan, Raajit Rampal, Mads Hald Andersen, Omar Abdel-Wahab, Nina Bhardwaj, Jedd D Wolchok, Ann Mullally, Taha Merghoub
Calreticulin mutant myeloproliferative neoplasms induce MHC-I skewing, which can be overcome by an optimized peptide cancer vaccine. Science translational medicine 14 (649) (2022)
Morten Kranker Larsen, Vibe Skov, Lasse Kjaer, Natascha A Møller-Palacino, Rasmus K Pedersen, Morten Andersen, Johnny T Ottesen, Sabrina Cordua, Henrik E Poulsen, Morten Dahl, Trine A Knudsen, Christina Schjellerup Eickhardt-Dalbøge, Steffen Koschmieder, Kasper M Pedersen, Yunus Çolak, Stig Egil Bojesen, Børge G Nordestgaard, Thomas Stiehl, Hans Carl Carl Hasselbalch, Christina Ellervik
Clonal haematopoiesis of indeterminate potential and impaired kidney function-A Danish general population study with 11 years follow-up. European journal of haematology 109 (5) (2022)
Jean-Jacques Kiladjian, Christoph Klade, Pencho Georgiev, Dorota Krochmalczyk, Liana Gercheva-Kyuchukova, Miklos Egyed, Petr Dulicek, Arpad Illes, Halyna Pylypenko, Lylia Sivcheva, Jiří Mayer, Vera Yablokova, Kurt Krejcy, Victoria Empson, Hans Carl Carl Hasselbalch, Robert Kralovics, Heinz Gisslinger, null null
Long-term outcomes of polycythemia vera patients treated with ropeginterferon Alfa-2b. Leukemia 36 (5) (2022)
Marc J B Dam, Rasmus Kristoffer Pedersen, Trine Alma Knudsen, Morten Andersen, Christina Ellervik, Morten Kranker Larsen, Lasse Kjaer, Vibe Skov, Hans Carl Carl Hasselbalch, Johnny T Ottesen
A novel integrated biomarker index for the assessment of hematological responses in MPNs during treatment with hydroxyurea and interferon-alpha2. Cancer medicine (2022)
Hans Carl Carl Hasselbalch, Vibe Skov, Lasse Kjær, Morten Kranker Larsen, Trine Alma Knudsen, Marko Lucijanic, Rajko Kusec
Recombinant Interferon-β in the Treatment of Polycythemia Vera and Related Neoplasms: Rationales and Perspectives. Cancers 14 (22) (2022)
Christina Schjellerup Eickhardt-Dalbøge, Anna Cäcilia Ingham, Lee O'Brien Andersen, Henrik Vedel Nielsen, Kurt Fuursted, Christen Rune Stensvold, Morten Kranker Larsen, Lasse Kjær, Sarah Friis Christensen, Trine Alma Knudsen, Vibe Skov, Christina Ellervik, Lars Rønn Olsen, Hans Carl Carl Hasselbalch, Xiaohui Chen Nielsen, Jens Jørgen Elmer Christensen
The Gut Microbiota in Patients with Polycythemia Vera is Distinct from that of Healthy Controls and Varies by Treatment. Blood advances (2022)
Arthur E Frankel, Renuka Reddy, Kayla R DeSuza, Khaled Deeb, Aaron F Carlin, Davey Smith, Yushuang Xie, Eknath Naik, Richard T Silver, Hans Carl Carl Hasselbalch
Response to pegylated interferon in a COVID-19-positive elderly woman with primary myelofibrosis treated with ruxolitinib. Clinical case reports 9 (4) (2021)
Marc J B Dam, Rasmus K Pedersen, Trine A Knudsen, Morten Andersen, Vibe Skov, Lasse Kjaer, Hans Carl Carl Hasselbalch, Johnny T Ottesen
Data-driven analysis of the kinetics of the JAK2V617F allele burden and blood cell counts during hydroxyurea treatment of patients with polycythemia vera, essential thrombocythemia, and primary myelofibrosis. European journal of haematology 107 (6) (2021)
Trine Alma Knudsen, Vibe Skov, Kristen E Stevenson, Lillian Werner, William Duke, Charles Laurore, Christopher James Gibson, Anwesha Nag, Aaron R Thorner, Bruce Wollison, Dennis Lund Hansen, Christina Ellervik, Daniel El Fassi, Karin de Stricker, Lukas Frans Ocias, Mette Brabrand, Ole Weis Bjerrum, Ulrik Overgaard, Mikael Frederiksen, Thomas Kristensen, Torben Kruse, Mads Thomassen, Torben Mourits-Andersen, Marianne Tang Severinsen, Jesper Stentoft, Jørn Starklint, Donna Neuberg, Lasse Kjaer, Thomas S Larsen, Hans Carl Carl Hasselbalch, R Coleman Lindsley, Ann Mullally
Genomic Profiling of a Randomized Trial of Interferon-α versus Hydroxyurea in MPN Reveals Mutation-Specific Responses. Blood advances (2021)
Arthur E Frankel, Wai C Yip, Eknath Naik, Hans Carl Carl Hasselbalch
Response to pegylated interferon in a COVID-19 positive male with metastatic jejunal neuroendocrine tumor treated with everolimus. Clinical case reports 9 (6) (2021)
Hans Carl Carl Hasselbalch, Vibe Skov, Lasse Kjær, Torben L Sørensen, Christina Ellervik, Troels Wienecke
Myeloproliferative blood cancers as a human neuroinflammation model for development of Alzheimer's disease: evidences and perspectives. Journal of neuroinflammation 17 (1) (2020)
Rasmus Kristoffer Pedersen, Morten Andersen, Trine Alma Knudsen, Zamra Sajid, Johanne Gudmand-Hoeyer, Marc J B Dam, Vibe Skov, Lasse Kjaer, Christina Ellervik, Thomas Stauffer Larsen, Dennis Lund Hansen, Niels Pallisgaard, Hans Carl Carl Hasselbalch, Johnny T Ottesen
Data-driven analysis of JAK2V617F kinetics during interferon-alpha2 treatment of patients with polycythemia vera and related neoplasms. Cancer medicine 9 (6) (2020)
Sabrina Cordua, Lasse Kjaer, Vibe Skov, Niels Pallisgaard, Hans Carl Carl Hasselbalch, Christina Ellervik
Prevalence and phenotypes of JAK2 V617F and calreticulin mutations in a Danish general population. Blood 134 (5) (2019)
Nimesh A Jayasuriya, Alisa Devedzic Kjaergaard, Kasper Mønsted Pedersen, Anders Lindholm Sørensen, Marie Bak, Morten K Larsen, Børge Grønne Nordestgaard, Stig Egil Bojesen, Yunus Çolak, Vibe Skov, Lasse Kjaer, Janne Schurmann Tolstrup, Hans Carl Carl Hasselbalch, Christina Ellervik
Smoking, blood cells and myeloproliferative neoplasms: meta-analysis and Mendelian randomization of 2·3 million people. British journal of haematology 189 (2) (2019)
Anders Lindholm Sørensen, Mads Emil Bjørn, Caroline H Riley, Morten Holmstrøm, Mads Hald Andersen, Inge Marie Svane, Stine Ulrik Mikkelsen, Vibe Skov, Lasse Kjaer, Hans Carl Carl Hasselbalch, Claus H Nielsen
B-cell frequencies and immunoregulatory phenotypes in myeloproliferative neoplasms: Influence of ruxolitinib, interferon-α2, or combination treatment. European journal of haematology 103 (4) (2019)
Vardan Nersesjan, Kristoffer A Zervides, Anders Lindholm Sørensen, Lasse Kjaer, Vibe Skov, Hans Carl Carl Hasselbalch
The red blood cell count and the erythrocyte sedimentation rate in the diagnosis of polycythaemia vera. European journal of haematology 104 (1) (2019)
Morten Orebo Holmström, Hans Carl Carl Hasselbalch, Mads Hald Andersen
Neo-antigen specific memory T-cell responses in healthy individuals. Oncoimmunology 8 (7) (2019)
Stine Ulrik Mikkelsen, Lasse Kjaer, Mads Emil Bjørn, Trine Alma Knudsen, Anders Lindholm Sørensen, Christen Bertel Lykkegaard Andersen, Ole Weis Bjerrum, Nana Brochmann, Daniel El Fassi, Torben A Kruse, Thomas Stauffer Larsen, Hans Torben Mourits-Andersen, Claus Henrik Nielsen, Niels Pallisgaard, Mads Thomassen, Vibe Skov, Hans Carl Carl Hasselbalch
Safety and efficacy of combination therapy of interferon-α2 and ruxolitinib in polycythemia vera and myelofibrosis. Cancer medicine 7 (8) (2018)
Hans Carl Carl Hasselbalch, Morten Orebo Holmström
Perspectives on interferon-alpha in the treatment of polycythemia vera and related myeloproliferative neoplasms: minimal residual disease and cure? Seminars in immunopathology 41 (1) (2018)
Kasper Mønsted Pedersen, Marie Bak, Anders L Sørensen, Ann-Dorthe Zwisler, Christina Ellervik, Morten K Larsen, Hans Carl Carl Hasselbalch, Janne S Tolstrup
Smoking is associated with increased risk of myeloproliferative neoplasms: A general population-based cohort study. Cancer medicine 7 (11) (2018)
Mia Aaboe Jørgensen, Morten Orebo Holmström, Evelina Martinenaite, Caroline Hasselbalch Riley, Hans Carl Carl Hasselbalch, Mads Hald Andersen
Spontaneous T-cell responses against Arginase-1 in the chronic myeloproliferative neoplasms relative to disease stage and type of driver mutation. Oncoimmunology 7 (9) (2018)
Hans Carl Carl Hasselbalch
Molecular profiling as a novel tool to predict response to interferon-α2 in MPNs: The proof of concept in early myelofibrosis. Cancer 123 (14) (2017)
Morten Andersen, Zamra Sajid, Rasmus K Pedersen, Johanne Gudmand-Hoeyer, Christina Ellervik, Vibe Skov, Lasse Kjær, Niels Pallisgaard, Torben A Kruse, Mads Thomassen, Jesper Troelsen, Hans Carl Carl Hasselbalch, Johnny T Ottesen
Mathematical modelling as a proof of concept for MPNs as a human inflammation model for cancer development. PloS one 12 (8) (2017)